R&D Insight: Unique views into immuno-oncology

CAR-T cell therapy and antibody-drug conjugates are two promising innovative immunotherapy approaches, but amongst all of the recent news and publications, it can be challenging to stay ahead of the emerging trends.  This idea in brief is a quick executive summary that identifies emerging trends, new opportunities, and key players in the immuno-oncology landscape.  Discover new modalities, checkpoint inhibitors, biomarkers, and targets that are growing quickly in our latest executive summary.  Download and share here:

Immuno-oncology
Download the executive summary

Related CAS Insights

創薬

A review of the global efforts on COVID-19 vaccine development

March 29, 2021

Read article
創薬

ACE2という、疾病病因特定において潜在的に重要なレセプターを標的にする

December 15, 2022

Read article
創薬

ACS webinar on molecular glues and targeted protein degradation

October 12, 2022

Read article

Gain new perspectives for faster progress directly to your inbox.